Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization

American Journal of Cardiology

Volumn 97, Issue 7, 2006, Pages 1076-1081

  Teirstein, Paul S ^a   Price, Matthew J ^a   Mathur, Vandana S ^b,c   Madyoon, Hooman ^d,e   Sawhney, Neil ^a   Baim, Donald S ^f  

^a SCRIPPS CLINIC   (United States)

^b Mathur Consulting   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e Brotman Medical Center   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FENOLDOPAM; INULIN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE REGULATION; CATHETER; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG SAFETY; FEMALE; FIRST PASS EFFECT; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

AGED; BLOOD PRESSURE; CROSS-OVER STUDIES; DRUG DELIVERY SYSTEMS; FEMALE; FENOLDOPAM; GLOMERULAR FILTRATION RATE; HEART CATHETERIZATION; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; MALE; PILOT PROJECTS; RENAL INSUFFICIENCY, CHRONIC; VASODILATOR AGENTS;

EID: 33645059989     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.10.053     Document Type: Article

References (10)

1. P.A. McCullough, S.S. Soman Contrast-induced nephropathy Crit Care Clin 21 2005 261 280
2. L. Gruberg, G.S. Mintz, R. Mehran, G. Gangas, A.J. Lansky, K.M. Kent, A.D. Pichard, L.F. Satler, M.B. Leon The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency J Am Coll Cardiol 36 2000 1542 1548
3. G.W. Stone, P.A. McCullough, J.A. Tumlin, N.E. Lepor, H. Madyoon, P. Murray, A. Wang, A.A. Chu, G.L. Schaer, M. Stevens CONTRAST Investigators Fenoldopam mesylate for the prevention of contrast-induced nephropathy a randomized controlled trial JAMA 290 2003 2284 2291
4. J.A. Tumlin, A. Wang, P.T. Murray, V.S. Mathur Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion a pilot trial in the prevention of contrast nephropathy Am Heart J 143 2002 894 903
5. H. Madyoon, L. Croushore, D. Weaver, V. Mathur Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients Catheter Cardiovasc Interv 53 2001 341 345
6. A.A. Chamsuddin, K.J. Kowalik, H. Bjarnason, C.A. Dietz, M.S. Rosenberg, M.D. Gomes, C.M. McDermott, D.W. Hunter Using a dopamine type 1A receptor agonist in high-risk patients to ameliorate contrast-associated nephropathy Am J Roentgenol 179 2002 591 596
7. E. Schnurr, W. Lahme, H. Kuppers Measurement of renal clearance of inulin and PAH in the steady state without urine collection Clin Nephrol 13 1980 26 29
8. B.R. Cole, J. Giangiacomo, J.R. Ingelfinger, A.M. Robson Measurement of renal function without urine collection. A critical evaluation of the constant-infusion technic for determination of inulin and para-aminohippurate N Engl J Med 287 1972 1109 1114
9. V.K. Boppana, K.M. Dolce, M.J. Cyronak, J.A. Ziemniak Simplified procedures for the determination of fenoldopam and its metabolites in human plasma by high-performance liquid chromatography with electrochemical detection comparison of manual and robotic sample preparation methods J Chromatogr 487 1989 385 399
10. P. Liss, A. Nygren, U. Erikson, H.R. Ulfendahl Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla Kidney Int 53 1998 698 702